Aicaigou LogoB2B Wiki

Baohuoside I

Updated: 2026-08-02

Overview

Baohuoside I, also known as Icariside I, is a flavonoid glycoside extracted from Epimedium species, a genus of plants widely used in traditional Chinese medicine. It has gained attention for its bioactive properties, including potential benefits for bone health, anti-inflammatory effects, and neuroprotection. The compound is often studied for its role in modulating cellular pathways related to oxidative stress and inflammation. Research suggests Baohuoside I may influence osteoblast activity, making it a candidate for osteoporosis treatment. Its antioxidant properties are also under investigation for applications in age-related degenerative diseases. As a niche phytochemical, it is primarily sourced for research and high-end supplement formulations.

Physical and Chemical Properties

Baohuoside I is characterized by its flavonoid backbone with a sugar moiety, contributing to its moderate solubility in polar organic solvents. The compound exhibits stability under standard laboratory conditions but may degrade under prolonged exposure to light or high temperatures. Its melting point range (180-185°C) indicates a crystalline structure typical of glycosylated flavonoids. Spectroscopic analysis (e.g., NMR, MS) confirms its molecular structure, with key functional groups including hydroxyl and methoxy substituents. These features are critical for its bioactivity and interaction with biological targets. The compound's logP value suggests moderate lipophilicity, influencing its pharmacokinetic profile in research settings.

Main Applications

In pharmaceutical research, Baohuoside I is investigated for its potential to enhance bone formation by stimulating osteoblast differentiation. Preliminary studies indicate it may upregulate BMP-2 and Wnt/β-catenin signaling pathways, relevant to osteoporosis therapy. Its anti-inflammatory effects are attributed to NF-κB pathway inhibition, with potential applications in autoimmune conditions. The nutraceutical industry incorporates Baohuoside I into specialized supplements targeting joint health and longevity. Traditional medicine formulations leverage its adaptogenic properties, often in combination with other Epimedium constituents. Due to limited clinical data, current applications remain confined to preclinical studies and boutique health products.

Safety and Storage

As a research-grade compound, Baohuoside I requires handling with standard laboratory PPE, including gloves and eye protection. While acute toxicity data is limited, in vitro studies suggest a favorable safety profile at typical research concentrations (≤100 μM). Long-term storage recommendations include desiccated environments at -20°C for extended stability. Suppliers typically provide material in amber vials or foil-packed containers to prevent photodegradation. Bulk procurement should include verification of residual solvent levels (e.g., methanol) if used in extraction processes. Stability-indicating HPLC methods are recommended for quality control during storage.

B2B Procurement Guide

When sourcing Baohuoside I, prioritize suppliers with documented cGMP compliance and batch-specific certificates of analysis (COA). Key parameters to verify include purity (≥98% by HPLC), residual solvents, and heavy metal content. Consider requesting NMR spectra for structural confirmation, especially for first-time purchases. Lead times for custom extraction orders may range from 4-8 weeks, with MOQs typically starting at 10 grams. For pilot-scale production, inquire about scalability and consistency across batches. Pricing tiers generally reflect purity levels, with pharmaceutical-grade material commanding premiums of 30-50% over standard research-grade product.

Related Manufacturers